RecruitingNCT07042321

Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients

Triglyceride Glucol Index for Predicting the Value of No-Reflow in Patients Undergoing Emergency PCI for Acute Myocardial Infarction


Sponsor

The Third Xiangya Hospital of Central South University

Enrollment

300 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective cohort study is to investigate the relationship between the TyG index and early identification of MVO in AMI patients undergoing emergency PCI and CMR imaging. The study will enroll approximately 300 AMI patients treated at Xiangya Third Hospital of Central South University from June 2024 to August 2025. The main questions it aims to answer are: * How does the TyG index correlate with the early detection of MVO? * What differences in cardiovascular adverse events during hospitalization exist between groups with varying TyG index levels? Participants will undergo emergency PCI and CMR imaging within 3-7 days post-procedure. Data collected will include demographic characteristics, clinical history, coronary angiography data, laboratory test indicators (especially metabolic markers such as blood glucose and lipids), IVUS-related plaque information, and CMR results.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age ≥ 18 years.
  • STEMI symptom onset time < 12 hours.
  • STEMI symptom onset time 12-48 hours, with ongoing ischemic symptoms, hemodynamic instability, or life-threatening ventricular arrhythmias.
  • Very high-risk NSTEMI; undergoing emergency PCI treatment.
  • Voluntary signed informed consent form.

Exclusion Criteria5

  • Non-obstructive acute myocardial infarction.
  • Severe chronic kidney disease (defined as estimated glomerular filtration rate <20 mL/min per 1.73 m²).
  • Pregnant women or those planning to become pregnant.
  • Failure of emergency PCI.
  • Unclear CMR images

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Xiangya Third Hospital of Central South University

Changsha, Hunan Province,China, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07042321


Related Trials